A Fatal Case of Candida auris and Candida tropicalis Candidemia in Neutropenic Patient
- 552 Downloads
We report a fatal case of Candida auris that was involved in mixed candidemia with Candida tropicalis, isolated from the blood of a neutropenic patient. Identification of both isolates was confirmed by amplification and sequencing of internal transcribed spacer and D1/D2 domain of large subunit in rRNA gene. Antifungal susceptibility test by E-test method revealed that C. auris was resistant to amphotericin B, anidulafungin, caspofungin, fluconazole, itraconazole and voriconazole. On the other hand, C. tropicalis was sensitive to all antifungal tested. The use of chromogenic agar as isolation media is vital in detecting mixed candidemia.
KeywordsMixed candidemia Multidrug resistant Candida auris
Earlier before the introduction of chromogenic agar and molecular methods, candidemia has been generally considered to be an infection caused by one Candida species, due to the limitation of conventional microbiological techniques which were not able to distinguish more than one species of yeast in patient’s samples. However, for the past two decades, with the growing numbers of immunocompromised and the improvement of diagnostic methods, the probability of the clinician encountered mixed infection of candidemia is increasing [1, 2].
The incidence of mixed candidemia (MC) is relatively low, ranging from 2 to 9.3% of total candidemia [3, 4, 5]. Candida albicans is the common species involved in MC, and the most common combination was C. albicans + C. glabrata  and C. albicans + C. parapsilosis . Other species including C. tropicalis, C. krusei, C. dubliniensis and C. glabrata also had been reported to cause MC [2, 6]. However, uncommon Candida species, particularly C. auris, has never been reported in MC cases. C. auris is an emerging, multidrug-resistant yeast that causes invasive infections and is transmitted in health care settings. Since it was first described in 2009, cases of C. auris candidemia had been reported in Asia, Europe, the Middle East and the USA [7, 8, 9, 10]. In fact, there have been discrete outbreaks globally, especially in the UK and the USA . This is the first report on isolation of C. auris from the blood of neutropenic patient, involved in a MC with C. tropicalis.
A 63-year-old retired construction worker with no significant medical history was presented to Kampar Hospital with generalized colicky abdominal pain associated with loose stool of 1-week duration and no bleeding tendency. He was afebrile but complained loss of appetite and weight for the past 1 month. On examination, the patient was noted to be pale with fever of 38 °C. No abnormality and no lymphadenopathy were detected during abdominal examination. Other respiratory, cardiovascular and muscular and neurology systems were unremarkable.
Initial complete blood count on the day of admission revealed pancytopenia with low reticulocyte response. Full blood picture examination revealed leukopenia and dysplastic neutrophils. He was referred to the state’s hospital for further investigation and management with the working diagnosis of febrile neutropenia to rule out myelodysplastic syndrome.
He was started on intravenous (IV) tazocin 4.5 g four times a day and IV gentamicin 120 mg daily. Septic work out (blood and urine culture) that was performed during day 1 and day 4 admissions was negative for any micro-organism. However, gram stain from the blood culture which was taken on day 9 demonstrated yeast-like cells. Subsequently, a dosage of 400 mg/day once a day of IV fluconazole was started following the positive finding.
Despite antifungal treatment given, the clinical condition of the patient remained febrile throughout his hospital stay. On day 15, IV imipenem 500 mg was started due to persistent temperature of 40 °C. On the next day, his Glasgow Coma Scale suddenly dropped from full score to M4 V2 E2, and he was subsequently intubated. Computed tomography finding of the brain revealed left parietal region bleed with midline shift. Nevertheless, neurosurgical team was unable to proceed with surgical intervention as his platelet count was still low despite the transfusion given. Patient’s clinical condition deteriorated further, and he succumbed to the illness 2 days later.
Identification of isolates UZ1446 and UZ1447 using API 20C, Vitek 2 and BLAST search of ITS and LSU regions
Isolate identification system
API 20C (%)
C. tropicalis (99.8)
Rhodotorula glutinis (99.3)
Vitek 2 (%)
C. tropicalis (99)
C. haemulonii (97)
GenBank accession number
C. tropicalis (100)
C. auris (98)
GenBank accession number
C. tropicalis (100)
C. auris (100)
DNA extractions, amplifications by polymerase chain reaction (PCR), PCR product purification and sequencing methods were performed as previously described . The internal transcribed spacer (ITS) and the D1/D2 domain of the large subunit (LSU) in rRNA gene regions were amplified using universal primers ITS5/ITS4  and NL1/NL4 . NCBI BLAST search (http://blast.ncbi.nlm.nih.gov/) was performed for the ITS and LSU sequences from both isolates. However, only sequences of isolate UZ1447 had been submitted to the GenBank (Table 1).
In Vitro Antifungal Susceptibility Testing (AST)
MICs and susceptibility interpretations of the isolates against antifungals
MIC (µg ml−1)
UZ1446 (C. tropicalis)
UZ1447 (C. auris)
> 32.000 (R)
< 0.002 (S)
> 256.000 (R)
> 32.000 (R)
This study reported a fatal case of C. auris, involved in mixed candidemia with C. tropicalis, isolated from neutropenia patient. The identification of both isolates was confirmed based on PCR sequencing of ITS region and D1/D2 domain in LSU region of the rRNA genes. The C. auris exhibited resistance to amphotericin B, anidulafungin, caspofungin, fluconazole, itraconazole and voriconazole.
On SDA, both isolates produced almost the same characteristics macro- and microscopically. Fortunately, chromogenic media like CHROMagar Candida was able to differentiate two types of colonies. The media is very useful to reveal of MC, in which if it is not been included in isolation media, MC can remain undetected by routine isolation methods. Few studies had shown the usefulness of chromogenic media in detecting mixed candidemia [2, 6, 16, 17, 18, 19]. In their studies, the incidence of MC ranged from 2.8 to 5.2%, with the most common species involved were C. albicans, C. parapsilosis, C. tropicalis and C. glabrata. Few Candida species including C. famata, C. krusei, C. lusitaniae, C. guilliermondii and C. dubliniensis were also reported but rarely caused MC. To the best of our knowledge, C. auris has never been reported to cause MC, thus this study is the first to report on MC involving C. auris.
Uncommon Candida species was difficult to identify using conventional phenotypic methods. The database limitation of commercial identification system may lead incorrect identification of these species. Thus, PCR sequencing of the ITS and D1/D2 domain in LSU regions is one of the reliable methods for uncommon Candida species identification [20, 21]. Besides that, MALDI-TOF that uses protein for identification was able to identify C. auris . Thus, in laboratories that rely on commercial identification systems, some important species like C. auris was under reported. The incorrect identification of multidrug resistance species will lead to the inappropriate antifungal treatment to the patient especially to those who are immunocompromised. Awareness on this issue should be emphasized among the diagnostic laboratories, so that the precautions can take place to avoid transmission of multidrug resistance C. auris in health care settings.
In this study, in vitro AST of C. tropicalis and C. auris revealed different susceptibility patterns. While C. tropicalis was all sensitive, C. auris was resistance to six antifungal drugs tested. The finding explained why clinical condition of the patient remained febrile, even though he was treated with fluconazole. Nevertheless, the patient died before the antifungal susceptibility results were available. Neutropenia condition, prolonged hospital stay, the use of broad-spectrum antibiotics and the presence of central venous catheters had been identified as risk factors which exposed immunocompromised patient to candidemia [23, 24]. After the first isolation of C. auris, to date we have not received other C. auris isolates from the same or any other hospital in Malaysia. Under-reported cases might be the reason why this situation happened.
The use of chromogenic agar as isolation media is vital in detecting mixed candidemia. Due to the limitation of commercial system like API 20C and Vitek 2, PCR sequencing method is foremost in identifying uncommon yeast species. With resistance to the main antifungal groups i.e. azoles, polyene and echinocandin, the treatment for C. auris infection has now become very challenging.
The authors would like to thank the Director General of Health, Malaysia, and the Director of Institute for Medical Research for permission to publish this article. We would also like to acknowledge the Microbiology Unit, Department of Pathology, Raja Permaisuri Bainun Hospital, for providing the yeast isolates.
Compliance with Ethical Standards
Conflict of interest
The authors declare that they have no conflict of interest.
All procedures performed in studies involving human participant were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
- 5.Pappas PG, Rex JH, Lee J, Hamill RJ, Larsen RA, Powderly W, Kauffman CA, Hyslop N, Mangino JE, Chapman S, Horowitz HW, Dismukes WE, NIAID Mycoses Study Group. A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients. Clin Infect Dis. 2003;37(5):634–43.CrossRefPubMedGoogle Scholar
- 9.European Centre for Disease Prevention and Control. Candida auris in healthcare settings—Europe (2016). https://ecdc.europa.eu/sites/portal/files/media/en/publications/Publications/Candida-in-healthcare-settings_19-Dec-2016.pdf. Accessed 7 Nov 2017.
- 11.Centers for Disease Control and Prevention. Clinical alert to US healthcare facilities—(2016). Global emergence of invasive infections caused by the multidrug-resistant yeast Candida auris. http://www.cdc.gov/fungal/diseases/candidiasis/candida-auris-alert.html. Accessed 7 Nov 2017.
- 14.O’Donnell K. Fusarium and its near relatives. In: Reynolds DR, Taylor JW, editors. The fungal holomorph: mitotic, meiotic and pleomorphic speciation in fungal systematics. Wallingford: CAB International; 1993. p. 225–33.Google Scholar
- 15.Clinical and Laboratory Standards Institute (CLSI). Reference method for broth dilution antifungal susceptibility testing of yeasts; 4th Informational Supplement. CLSI document M27-S4. Wayne: Clinical and Laboratory Standards Institute; 2012.Google Scholar
- 22.Girard V, Mailler S, Chetry M, Vidal C, Durand G, van Belkum A, Colombo AL, Hagen F, Meis JF, Chowdhary A. Identification and typing of the emerging pathogen Candida auris by matrix-assisted laser desorption ionisation time of flight mass spectrometry. Mycoses. 2016;59:535–8.CrossRefPubMedGoogle Scholar
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.